Avestar Capital, LLC Teva Pharmaceutical Industries LTD Transaction History

Avestar Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$6.16 - $9.6 $0 - $0	0 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$8.12 - $15.72 $1,071 - $2,075	-132 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$15.58 - $20.01 $763 - $980	49 Added 59.04%	132 $1,000
Q4 2018 Jan 25, 2019	SELL	$14.59 - $23.84 $496 - $810	-34 Reduced 29.06%	83 $1,000
Q3 2018 Oct 23, 2018	BUY	$21.06 - $25.65 $231 - $282	11 Added 10.38%	117 $1,000

Q2 2018 Aug 10, 2018	BUY	$16.77 - $24.71 $1,777 - $2,619	106 New	106 $1,000
Q1 2018 May 10, 2018	BUY	$16.68 - $22.07 $0 - $0	0 New	0 $1,000

550

548M

19.8M

14M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18.9B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Avestar Capital, LLC with notifications on news.